Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

Overview of attention for article published in Journal of Hematology & Oncology, April 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 15 X posts from 14 X users, with an upper bound of 53,161 followers.

RT @SalmantonGarcia: Passive #PreExposure immunization by #tixagevimab_cilgavimab in #HemOnc patients w/ #COVID19: matched-paired analysis…

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients wi... https://t.co/ECisgJJLMm #GE51

RT @MichaelGIsonMD: We in the #TxID need to push for newer preventive MAbs for COVID-19 and other challenging infections. @AST_IDCOP

RT @SalmantonGarcia: Passive #PreExposure immunization by #tixagevimab_cilgavimab in #HemOnc patients w/ #COVID19: matched-paired analysis…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.